Kestra Advisory Services’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $114K | Sell |
12,700
-15
| -0.1% | -$134 | ﹤0.01% | 2718 |
|
|
2025
Q1 | $95.4K | Sell |
12,715
-100
| -0.8% | -$750 | ﹤0.01% | 2594 |
|
|
2024
Q4 | $96.4K | Buy |
+12,815
| New | +$96.4K | ﹤0.01% | 2562 |
|
|
2023
Q4 | – | Sell |
-18,779
| Closed | -$133K | – | 2274 |
|
|
2023
Q3 | $133K | Sell |
18,779
-7,300
| -28% | -$51.7K | ﹤0.01% | 1990 |
|
|
2023
Q2 | $184K | Buy |
26,079
+2,150
| +9% | +$15.1K | ﹤0.01% | 1918 |
|
|
2023
Q1 | $200K | Buy |
23,929
+2,395
| +11% | +$20K | ﹤0.01% | 1843 |
|
|
2022
Q4 | $247K | Buy |
21,534
+7,220
| +50% | +$82.9K | ﹤0.01% | 1876 |
|
|
2022
Q3 | $180K | Buy |
+14,314
| New | +$180K | ﹤0.01% | 1899 |
|